WYRGRL IS A TYPE II COLLAGEN-TARGETING PEPTIDE WITH AFFINITY FOR THE CARTILAGE MATRIX COMPONENTS OF COLLAGEN II. It can be used for the development of nanoplatforms for cartilage-targeted drug delivery.